文献速递间质性肺疾病

特发性肺纤维化患者肺功能与气体交换的纵向全基因组关联研究

Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study.
PubMed 文献 · Lancet Respir Med · 2022-08-16

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease characterised by progressive scarring leading to alveolar stiffness, reduced lung capacity, and impeded gas transfer.…

要点

  • rs115982800与IPF患者FVC年下降相关,每风险等位基因-140 mL/年。
  • 该变异位于PKN2反义RNA基因,PKN2抑制剂在研,或为IPF新治疗方向。
  • 研究未发现与DLCO下降全基因组显著相关的变异。

核心结论

  • 发现rs115982800与IPF患者FVC下降全基因组显著相关,PKN2为最可能相关基因。

研究设计与样本

  • 对三项研究(1996年6月至2017年8月,美国、英国、西班牙多中心)IPF患者纵向FVC和DLCO测量进行全基因组meta分析。
  • FVC分析纳入1329例患者共5216次测量,DLCO分析纳入975例患者共3361次测量。
  • 在独立研究CleanUP-IPF中进一步验证提示显著变异,所有研究按ATS/ERS指南诊断IPF。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease characterised by progressive scarring leading to alveolar stiffness, reduced lung capacity, and impeded gas transfer. We aimed to identify genetic variants associated with declining lung capacity or declining gas transfer after diagnosis of IPF. METHODS: We did a genome-wide meta-analysis of longitudinal measures of forced vital capacity (FVC) and diffusing capacity of the lung for carbon monoxide (DLCO) in individuals diagnosed with IPF. Individuals were recruited to three studies between June, 1996, and August, 2017, from across centres in the US, UK, and Spain. Suggestively significant variants were investigated further in an additional independent study (CleanUP-IPF). All four studies diagnosed cases following American Thoracic Society/European Respiratory Society guidelines. Variants were defined as significantly associated if they had a meta-analysis p<5 × 10-8 when meta-analysing across all discovery and follow-up studies, had consistent direction of effects across all four studies, and were nominally significant (p<0·05) in each study. FINDINGS: 1329 individuals with a total of 5216 measures were included in the FVC analysis. 975 individuals with a total of 3361 measures were included in the DLCO analysis. For the discovery genome-wide analyses, 7 611 174 genetic variants were included in the FVC analysis and 7 536 843 in the DLCO analysis. One variant (rs115982800) located in an antisense RNA gene for protein kinase N2 (PKN2) showed a genome-wide significant association with FVC decline (-140 mL/year per risk allele [95% CI -180 to -100]; p=9·14 × 10-12). INTERPRETATION: Our analysis identifies a genetic variant associated with disease progression, which might highlight a new biological mechanism for IPF. We found that PKN2, a Rho and Rac effector protein, is the most likely gene of interest from this analysis. PKN2 inhibitors are currently in development and signify a potential novel therapeutic approach for IPF. FUNDING: Action for Pulmonary Fibrosis, Medical Research Council, Wellcome Trust, and National Institutes of Health National Heart, Lung, and Blood Institute.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Allen RJ, Oldham JM, Jenkins DA, et al. Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study. Lancet Respir Med. 2022. PMID: 35985358. doi:10.1016/S2213-2600(22)00251-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。